Table 1.
Characterization of a sample of 500 participants in the Stroke Prevention Campaign who underwent carotid stenosis screening.
| Total | ||
| Age (years) | ||
| Mean±S.D. | 67.8±6.4 | |
| Median | 66.0 | |
| Minimum-maximum | 60–89 | |
| Gender - n (%) | ||
| Female | 279 | (55.8%) |
| Male | 221 | (44.2%) |
| Race - n (%) | ||
| White | 413 | (82.6%) |
| Black | 60 | (12.0%) |
| Yellow | 27 | (5.4%) |
| Signs and symptoms of stroke - n (%) | ||
| Asymptomatic | 255 | (51.0%) |
| Visual symptoms | 57 | (11.4%) |
| Syncope | 53 | (10.6%) |
| Sequelae | 18 | (3.6%) |
| Variables - n (%) | ||
| SAH | 364 | (72.8%) |
| Dyslipidemia | 250 | (50.0%) |
| Family history of stroke | 215 | (43.0%) |
| Smoking | 182 | (36.4%) |
| CI (angina, angioplasty or coronary artery bypass) | 122 | (24.4%) |
| DM | 116 | (23.2%) |
| PAOD | 107 | (21.4%) |
| Cardiopathy | 90 | (18.0%) |
| Bruit | 10 | (2.0%) |
| Total | 500 | (100.0%) |
SAH: Arterial hypertension; CI: Coronary insufficiency; DM: Diabetes mellitus; PAOD: Peripheral obstructive arterial disease.